Providing Unique Whole Solutions to SARS-CoV-2 T throat, myalgia and diarrIntroduction For more than 20 years, ACON has led the way in making high quality diagnostic and medical devices more affordable to people all around the world, In fact, the ACON name is well known in over 150 countries. Headquartered in. San Diego, California, the US office is the center of strategic management, administration, business development, innovative research and development. Our state of the art manufacturing facility is SO 13485:2016 certified, FDA registered, and has been inspected by US FDA, ‘Our current product lines include Diabetes Care, Clinical Chemistry s and Point of Care Tests), Rapid Test, Immunoassay (EIA/ELISA and Allergen Test) and Molecular Diagnostics. As a alobal enterprise, we also have distributors all around the world who contribute to our products development, international sales and technical support. Disclaimer: Some products in this brochure may not be available in all countries. Please consult with your local ACON sales representative for details ACON History 1995, ACON was founded Founded in Bethlehem, PA, USA, ACON operated in a 27,000 sq, f manufacturing facility 1999 Moved to San Diego, CA, USA 2001 Became a large manufacturer ACON increased our manufacturing facility to 150,000 sq.ft with more than 1,500 employees 2006 Launched new product lines [ACON sold the LF (lateral flow) rapid diagnostic business in the US, Europe, Canada, Israel, Japan, ‘Australia, and New Zealand, We launched and started to focus on new product lines including Diabetes Care, Clinical Chemisty, and Immunoassay. 2009 Expanded product lines [ACON sold the LF rapid diagnostic business in Asia, the Middle East, Africa and Latin America, We continued to expand our business in Diabetes Care, Clinical Chemistry, and Immunoassay. 2015 Moved to a much larger facility for manufacture, R&D and business development Our new faclty of 70000 sq, m (750,000 sq, FU) includes state-ofthe-art manufacturing equipment to supply the growing demand ofthe global diagnostic marke. 2018 Centralised and Point of Care Solutions ‘The Centralised and Point of Care Solutions were launched to offer a better solution, and the business expanded globally. Future Looking forward We hope to develop more products to meet the IVD and Medical Diagnostic matket needs by expanding diagnostic and healthcare services.Serology Testing SARS-CoV-2 IgG/IgM Rapid Test A rapid test for the qui ve detection of IgM and IgG antibodies to the SARS-CoV-2 in serum, plasma, venous whole blood, or capillary fingertip blood. * Key Features and Performance Feat 7 ern oy Detection IgM andi atbodies to SARSCoV-2 Specinen Serum, Pls, Venous Whole lod, Coplay Fingertip Blood Serathty so94ct 08) cE Speccty 98. INOSNCE62%-9.5%) ae eee Materials Provided Test Time 15-20 minutes Shelf life 12 months: ie aoe SRE sae q ® vs So CSV © x negative 1 oopetiogete le |{ |e ||) le |{ lle Hie Lf ||) agama aoe »> (a ‘natia Ordering Information a Coe <= [ACONSARS-COV-2IGG/IgMRapldTest LORIN Cassette Serum, PlasmaWholeblood 25 Testkt VCE mated sans co yor ‘choot ad te secon ap est esa atm eg ee wth nape manana SARS 2. at cnr rerio alten SARS gggSerology Testing SARS-CoV-2 IgG EIA Test Kit Foresight’ SARS-CoV-2 IgM EIA Test Kit - “The SARS-CoV-2 IgG and IgM E1A Test Kits are two qualitative enzyme, immunoassay for the detection of lgG or IgM antibodies to SARS-CoV-2 inhuman serum or plasma High Quality + High sensitivity and specfcky + High reproducibly + Consistent and reliable performance at compete pricing ‘Simple and Easy to Use + Total incubation time a short as 70 minutes + Simplified procedure designed for added convenience . + Color-caded and numbered reagents for easy handing + Ready touse reagents shorten intial preparation Convenient + Allnecessary reagents provided + Breakaway 8 wel tris in 96 microwell platen resealable foil pouch + Cambe performed on automated sample processors + Shelf fe up to 12 months Key Features and Performance Detection IgG antibodies to SARS-Cov.2 IgM antibodies to SARS-CoV-2 “Type ofTest Qualitative Oualtative Specimen Type SerunyPlasma Serum/Plsma Specimen Volume Sul ou “Total Incubation Time 70 min (30/30/10) omin (30/30/10) Sensitivity 95.2% 905% Specificity 98.0% 905% (Overall Agreement 978% 98.1% ‘Within-Run Precision CVs) m% < Between Run Precision CV) oe ow Shel Life 12 months 12months Ordering Information a SARS-CoV-2IgG EIA Test Kit 1231-1321 SerunPlasma 96/480 Testi SARS-CoV-2IgMEIA Test Kit 1231-1331 Serum/Plasma 96/480 Tests TAC 2 ang EIA est sr oi st eect tupac cases wh nd a gate onining wih neo etn nthe gross ‘a is Hom SAISCOV2 on est sob ed ase ado a ee SARS-Cat2hkctonMolecular Diagnostics NES-32 Nucleic Acid Extration System Promotor’ —_— Efficient and easy to operate nucleic acid extraction system (Magnetic Beads). + Getexracted product within 40 minutes. + Maximum 32 specimen processed atatime, + Ready-toxse extraction plate provided. + High purity and good CV performance. + Lowlossrate of magnetic beads + UY sterilization and disposable consumables eliminate contamination. Viral Nucleic Acid Isolation Kit (Spin Column) Use a simple, rapid protocol to generate high-quality templates fora broad range ‘of downstream applications. + Fast procedures and easy touse, + lbolation and purification of high-qualty vir ONA/RNA. + High efficent recovery yield + Pure DNA/RNA ready for downstream applications. + No phenol-chloroform extraction. DNAIRNA RNA Ordering Information a NES-32Nucleic Acid Extraction PIII-I011Y— Magnetic, Serum, Plasma, Whole blood, 1 Unit system Separation Analyzer Swabs or Feces Nucleic Acid extraction kit P12-1301Y — MagneticBeads Serum, Plasma or Swabs 32 Tests/Kit Nucleic Aci (RNA) Extraction Kit PI2I-1721Y Magnetic Beads Serum, Plasma, Swabs or Feces 32Tests/Kit Nucleic Acid (RNA) Extraction Kit P12I-1221Y Magnetic Beads Serum, Plasma, Swabs or Feces 32Tests/Kit (ready-to-use) Viral DNA/RNA Isolation Kit P12-1291Y Spin Column Serum, Plasma or Swabs 32/50Tests/Kit Viral Nucleic Aid Isolation Kit P121-1051Y Spin Column Serum, Plasma or Swabs 32 Tests/Kit CE markedMolecular Diagnostics 960 Real-Time PCR System Promotor’ —_—— Key Features and Performance [Features ee era ese Peles based 96 weleock MaxBlok amp Rate 50s ax Block Coolng Rate aes a sare Temperate Uno t55) <0. Chanel aaa Compatble Dyes Chanel: FAM, SYR Gree: Chane 2: VG EX JOE TET nel AO. Tess dr Chanel CYS ST o-oo} Optical System Long life LED and PMT Mulilexanayis Uptostargts peel SARS-CoV-2 RT PCR Test Kit + Single-well, ipl target assay covering high conserved regions within N,Eand ORFlab gene for high specificity. + Ful: process controls with negative, positive and internal cont. + Qualitative detection of nuclei acids rom SARS-CoV2.* Key Features and Performance a Technology eab Time reverse transcription polymerase chain reaction (RT-PCR) Target Region NE ORFIab Specimen Type (Oropharyngeal swab, nasopharyngeal swab and deep cough sputum Internal Control Yes Minimum Sample Volume. 200 Test Duration ‘90 minutes Limit of Detection 500 copies. Precision of n-batch and batch (CV) om Positive Percent Agreement 97 46% (95W6CI:92.7586 99.47%) Negative Percent Agreement 98.26% (95%6Ci:94.99%-99.64%) ‘Accuracy 97.93% (OS¥CI:95.553-99.24%) Storage Temperature 2ossec Package Size a2Testsit Ordering Information SARSCOVPCR Raton Eyre SARSCOVORTICRTER BTS pacar ae Sennen PCR sument Ur apnea Mana pee ae footers samara Seu tubes, “al anette th poten nena ote gration esa ote pte fect Sa ACON Biotech (Hangzhou) Co. Ltd. Ne2i0zherahong Rod West Lake Dstt Hangzhou. FRChina, 310050, Tek s9657187775737 Foe 186.571.8777 5781 Eatmarketngteaconbcomen —— Webrrwwaconsbscom